Karolina KęPińska
Karolina KęPińska has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jakub Dariusz Kałdowski1 shared publication
- Kamil Adasiewicz
Celon Pharma S.A., Research and Development Center, 15 Marymoncka, 05-152 Kazuń Nowy, Poland
1 shared publication - Michal Gorka
Max-Planck-Institute of Molecular Plant Physiology, Am Mühlenberg 1, 14476 Potsdam-Golm, Germany
1 shared publication - Michał Adam Laszczyk1 shared publication
Latest Publications
- Open Access
- 7 September 2026
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 83 (3) , 303-316
Green and High-Throughput Quantification of Semaglutide in Bulk Substance and Solutions for Injections Using Liquid Chromatography
A rapid and robust reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and fully validated strictly as a quantitative assay for the high-throughput determination of semaglutide (SMG) in both active pharmaceutical ingredient (API) powder and solutions for injection. Chromatographic separation was achieved on a Phenomenex Aeris™ 3.6 µm Widepore XB-C18 column (150 × 2.1 mm) using a mobile phase consisting of 100 mM ammonium dihydrogen phosphate buffer combined with acetonitrile , with the addition of perchloric acid using an isocratic elution. The advantage of the developed methodology is the compression of the total run time to 6 minutes, which introduces an over three-fold increase in throughput compared to existing methods. The method was successfully validated according to ICH Q2(R2) , showing specificity, linearity (R2 = 0.998 within 70%–130% range), precision (%RSD ≤ 1.73%) and accurate recovery (98.8% – 100.2%) for bulk and final formulation samples.
- 7 September 2026
- Published by Polish Pharmaceutical Society in Acta Poloniae Pharmaceutica - Drug Research
- Vol. 83 (3) , 303-316
Open AccessGreen and High-Throughput Quantification of Semaglutide in Bulk Substance and Solutions for Injections Using Liquid Chromatography
A rapid and robust reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and fully validated strictly as a quantitative assay for the high-throughput determination of semaglutide (SMG) in both active pharmaceutical ingredient (API) powder and solutions for injection. Chromatographic separation was achieved on a Phenomenex Aeris™ 3.6 µm Widepore XB-C18 column (150 × 2.1 mm) using a mobile phase consisting of 100 mM ammonium dihydrogen phosphate buffer combined with acetonitrile , with the addition of perchloric acid using an isocratic elution. The advantage of the developed methodology is the compression of the total run time to 6 minutes, which introduces an over three-fold increase in throughput compared to existing methods. The method was successfully validated according to ICH Q2(R2) , showing specificity, linearity (R2 = 0.998 within 70%–130% range), precision (%RSD ≤ 1.73%) and accurate recovery (98.8% – 100.2%) for bulk and final formulation samples.